SAMAHA ELI sold 0.1% of their position (6.96K shares) of THERAVANCE BIOPHARMA, INC. on the open market
Open‑market sale worth $119.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/8/2026ACC: 0001877589-26-000002
-6.96K
Net shares
Net seller
$119.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
6.96K disposed
Non-Derivative Transactions2
COM
Indirect
Shares
−1.40K
Price / share
$17.04
Trade value
$23.86K
% of position
0.0%
7/6/2026
9.17M→9.17M
COM
Indirect
Shares
−5.56K
Price / share
$17.17
Trade value
$95.54K
% of position
0.1%
7/7/2026
9.17M→9.17M
Total
Net shares
−6.96K
Net value
-$119.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COM Indirect | 7/6/2026 | S · Sale | −1.40K | $17.04 | $23.86K | 0.0% | 9.17M | 9.17M |
| COM Indirect | 7/7/2026 | S · Sale | −5.56K | $17.17 | $95.54K | 0.1% | 9.17M | 9.17M |
| Total | −6.96K | -$119.40K | ||||||
Derivative Transactions0
No derivative transactions reported